Results 91 to 100 of about 77,970 (296)
HPV infections and immunosuppression [PDF]
Bouwes Bavinck, J.N., Berkhout, R.J.M.
openaire +3 more sources
What's New? Racial disparities in trends of human papillomavirus (HPV)–associated cancers in South Africa have received limited attention. Here, the authors examined cancer incidence rates among South Africans, with stratification by race and sex, for different timeframes across 2011–2022.
Adino T. Tsegaye +7 more
wiley +1 more source
BackgroundThe control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and ...
Unnop Jaisamrarn +29 more
doaj +1 more source
What's New? This study shows that absolute and relative educational inequalities in cervical cancer mortality are much larger in the Baltic countries than in Finland, where an organized screening programme was introduced more than 40 years earlier. After the introduction of organized screening, cervical cancer mortality declined among low‐educated ...
Oskar Nõmm +7 more
wiley +1 more source
HPV genital infections and contraception.
Human Papilloma Virus genital infections are, especially during fertile age, a very common finding in performing PAP smear and colposcopy. The interest in these infections arises from their frequent association with dysplasia and their possible role in the etiology of carcinoma of the lower genital tract.
LITTA, PIETRO SALVATORE +2 more
openaire +2 more sources
What's New? Hypoxic regions and inflammatory Th17 cells in the tumor environment are both associated with poor prognosis in cervical cancer. However, synergistic mechanisms between hypoxia and Th17 cells remain elusive. This study demonstrated Th17–hypoxia‐driven mechanisms underlying cervical cancer progression.
Selina Gies +12 more
wiley +1 more source
IntroductionCervical cancer is the fourth most commonly diagnosed malignancy among women globally, with HPV infection being the primary cause. Large-scale HPV screening is crucial for early detection, as appropriate intervention in HPV-positive ...
Weifeng Wei +16 more
doaj +1 more source
What's New? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon +2 more
wiley +1 more source
What's New? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll +11 more
wiley +1 more source

